Paclitaxel: As Adjuvant or Neoadjuvant Therapy in Early Breast Cancer

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.16, 2004-01, pp. : 1839-1847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controversies in breast cancer: adjuvant and neoadjuvant therapy

By Montemurro Filippo Redana Stefania Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1055-1072

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D Sarkar Tarun Hutcheon Andrew W

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for early breast cancer

By Mieog J Sven D van de Velde Cornelis JH

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1423-1434

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer

Medicinal Chemistry, Vol. 12, Iss. 3, 2016-05 ,pp. : 261-267

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant docetaxel, vinorelbine and trastuzumab prior to surgery and adjuvant therapy is active in patients with HER-2 breast cancer

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite